NIDA supports epidemiology, plan study and general public health and fitness outcomes study relevant to cannabis use, such as the Monitoring the Future survey and a medicinal cannabis use registry.In 2024, the U.S. Drug Enforcement Administration (DEA) indicated which they intend to reclassify cannabis for a Plan III drug. This rescheduling will un